262 related articles for article (PubMed ID: 21778132)
1. The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinoma.
Dahmani R; Just PA; Perret C
Clin Res Hepatol Gastroenterol; 2011 Nov; 35(11):709-13. PubMed ID: 21778132
[TBL] [Abstract][Full Text] [Related]
2. Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment.
Vilchez V; Turcios L; Marti F; Gedaly R
World J Gastroenterol; 2016 Jan; 22(2):823-32. PubMed ID: 26811628
[TBL] [Abstract][Full Text] [Related]
3. Destruxin B inhibits hepatocellular carcinoma cell growth through modulation of the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
Huynh TT; Rao YK; Lee WH; Chen HA; Le TD; Tzeng DT; Wang LS; Wu AT; Lin YF; Tzeng YM; Yeh CT
Toxicol In Vitro; 2014 Jun; 28(4):552-61. PubMed ID: 24434019
[TBL] [Abstract][Full Text] [Related]
4. Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells.
Yang W; Yan HX; Chen L; Liu Q; He YQ; Yu LX; Zhang SH; Huang DD; Tang L; Kong XN; Chen C; Liu SQ; Wu MC; Wang HY
Cancer Res; 2008 Jun; 68(11):4287-95. PubMed ID: 18519688
[TBL] [Abstract][Full Text] [Related]
5. Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFβ signaling pathways.
Coulouarn C; Cavard C; Rubbia-Brandt L; Audebourg A; Dumont F; Jacques S; Just PA; Clément B; Gilgenkrantz H; Perret C; Terris B
Carcinogenesis; 2012 Sep; 33(9):1791-6. PubMed ID: 22696594
[TBL] [Abstract][Full Text] [Related]
6. [Role of Wnt/β-catenin signaling pathway in promoting tumorigenesis of hepatocellular carcinoma].
Xie L; Jiang H; Wu F
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jun; 34(6):913-7. PubMed ID: 24968856
[TBL] [Abstract][Full Text] [Related]
7. From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.
Pang RW; Poon RT
Oncology; 2007; 72 Suppl 1():30-44. PubMed ID: 18087180
[TBL] [Abstract][Full Text] [Related]
8. Atypical regulators of Wnt/β-catenin signaling as potential therapeutic targets in Hepatocellular Carcinoma.
Chen J; Rajasekaran M; Hui KM
Exp Biol Med (Maywood); 2017 Jun; 242(11):1142-1149. PubMed ID: 28429652
[TBL] [Abstract][Full Text] [Related]
9. Molecular targeted therapy for hepatocellular carcinoma: bench to bedside.
Kudo M
Dig Dis; 2011; 29(3):273-7. PubMed ID: 21829017
[TBL] [Abstract][Full Text] [Related]
10. Wnt/beta-catenin signaling pathway in hepatocellular carcinomas cases from Colombia.
Suarez M I; Uribe D; Jaramillo CM; Osorio G; Perez JC; Lopez R; Hoyos S; Hainaut P; Pineau P; Navas MC
Ann Hepatol; 2015; 14(1):64-74. PubMed ID: 25536643
[TBL] [Abstract][Full Text] [Related]
11. Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma.
Kim YD; Park CH; Kim HS; Choi SK; Rew JS; Kim DY; Koh YS; Jeung KW; Lee KH; Lee JS; Juhng SW; Lee JH
J Gastroenterol Hepatol; 2008 Jan; 23(1):110-8. PubMed ID: 18171349
[TBL] [Abstract][Full Text] [Related]
12. Wnt/beta-catenin pathway in hepatocellular carcinoma pathogenesis and liver physiology.
Cavard C; Colnot S; Audard V; Benhamouche S; Finzi L; Torre C; Grimber G; Godard C; Terris B; Perret C
Future Oncol; 2008 Oct; 4(5):647-60. PubMed ID: 18922122
[TBL] [Abstract][Full Text] [Related]
13. Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs.
Pez F; Lopez A; Kim M; Wands JR; Caron de Fromentel C; Merle P
J Hepatol; 2013 Nov; 59(5):1107-17. PubMed ID: 23835194
[TBL] [Abstract][Full Text] [Related]
14. [The role and significance of Wnt/beta-catenin signaling pathway regulating the signaling molecules in hepatocellular carcinoma].
Wang XH; Sun X; Meng XW; Lü ZW; Liu MN; Pei FH
Zhonghua Gan Zang Bing Za Zhi; 2010 Sep; 18(9):672-5. PubMed ID: 20943078
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathogenesis and targeted therapy of hepatocellular carcinoma.
Zender L; Kubicka S
Onkologie; 2008 Oct; 31(10):550-5. PubMed ID: 18854656
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of Wnt/β-catenin signaling by protein kinases in hepatocellular carcinoma and its therapeutic application.
Li Q; Sun M; Wang M; Feng M; Yang F; Li L; Zhao J; Chang C; Dong H; Xie T; Chen J
Cancer Sci; 2021 May; 112(5):1695-1706. PubMed ID: 33605517
[TBL] [Abstract][Full Text] [Related]
17. Novel candidate targets of Wnt/beta-catenin signaling in hepatoma cells.
Lee HS; Park MH; Yang SJ; Park KC; Kim NS; Kim YS; Kim DI; Yoo HS; Choi EJ; Yeom YI
Life Sci; 2007 Jan; 80(7):690-8. PubMed ID: 17157329
[TBL] [Abstract][Full Text] [Related]
18. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.
Qin X; Zhang H; Zhou X; Wang C; Zhang H; Zhang X; Ye L
Transl Res; 2007 Nov; 150(5):281-94. PubMed ID: 17964517
[TBL] [Abstract][Full Text] [Related]
19. Action and function of Wnt/β-catenin signaling in the progression from chronic hepatitis C to hepatocellular carcinoma.
Wang W; Pan Q; Fuhler GM; Smits R; Peppelenbosch MP
J Gastroenterol; 2017 Apr; 52(4):419-431. PubMed ID: 28035485
[TBL] [Abstract][Full Text] [Related]
20. Points of therapeutic intervention along the Wnt signaling pathway in hepatocellular carcinoma.
Nambotin SB; Wands JR; Kim M
Anticancer Agents Med Chem; 2011 Jul; 11(6):549-59. PubMed ID: 21554202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
